EMCDDA 25 let monitorování
V roce 2020 slaví EMCDDA 25 let sledování drogové situace v Evropě.
Search
Stipendia EU4MD pro mezinárodní fórum NIDA 2020
Odborníci, akademičtí pracovníci a odborníci ze zemí evropské politiky sousedství (EPS) budou mít příležitost zúčastnit se mezinárodního fóra Národního institutu pro zneužívání drog v roce 2020 díky pěti stipendiím, která jsou nabízena...
ASAP-Training Newsletter
The aim of the ASAP training project is to build effective drug prevention results across Europe, based on prevention systems analysis and widespread professional training.
The ASAP training project will work to identify the strengths and...
EU Drug Markets Report 2019
The EU Drug Markets Report 2019 is the third comprehensive overview of illicit drug markets in the European Union by the EMCDDA and Europol.
The analysis presented in the report examines topics such as the links between drugs and other...
Monitoring the Elimination of Viral Hepatitis as a Public Health Threat in Europe
This technical report focuses on an elimination barometer for viral hepatitis to help countries assess progress towards eliminating hepatitis C and B among people who inject drugs (PWID).
The barometer is being developed by the EMCDDA...
Prevention of Drug-Related Deaths
Opioids are a class of drugs that act on the nervous system to produce feelings of pleasure and pain relief. Opioids have a high potential for causing addiction in some people and can cause life-threatening health problems, including the...
EDPQS Toolkit 4: Adaptation and Dissemination
The European Drug Prevention Quality Standards have been 
established to provide a comprehensive set of criteria to help users learn how to recognise 'high quality' prevention activities, outline the necessary structurally and procedural...
EDPQS Toolkit 3: Školení
Evropské normy kvality protidrogové prevence byly 
zavedeny s cílem poskytnout komplexní soubor kritérií, která uživatelům pomohou naučit se rozpoznávat "vysoce kvalitní" preventivní činnosti, nastínit nezbytné strukturální a procedurální...
EDPQS Toolkit 2: Self-Assessment & Reflection
The European Drug Prevention Quality Standards have been 
established to provide a comprehensive set of criteria to help users learn how to recognise 'high quality' prevention activities, outline the necessary structurally and procedural...
EDPQS Toolkit 1: Financování a rozhodování
Evropské normy kvality protidrogové prevence byly zavedeny s cílem poskytnout komplexní soubor kritérií, která uživatelům pomohou 
naučit se rozpoznávat "vysoce kvalitní" preventivní činnosti, nastínit nezbytné strukturální a procedurální...
Hepatitida C Nové modely péče o drogové služby
Infekce virem hepatitidy C (HCV) má vysokou prevalenci u lidí, kteří si v Evropě aplikují drogy injekčně, ačkoli infekci HCV lze předcházet i léčit.
Evropské klinické pokyny doporučují, aby všichni pacienti s chronickým onemocněním jater...
Infografika: Evropská zpráva o drogách za rok 2019
EMCDDA vyvinulo řadu infografiky ke stažení , které ilustrují zjištění z Evropské zprávy o drogách za rok 2019.
Cílem zprávy je poskytnout spolehlivé a podrobné důkazy o drogové situaci v Evropě, aby praxe a nové politiky mohly být...
European Drug Report (EDR) 2019: Trends and Developments
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has published the latest European Drug Report, which provides an analysis of the latest data on the drug trends across the European Union, Norway and Turkey.
The aim of...
Xchange Prevention Registry
Xchange is an online registry of evidence-based prevention programmes. In its first phase, the registry will make available manualised interventions that European evaluation studies show have beneficial outcomes relating to substance use...
Drug-Related Homicide in Europe: A First Review of the Data and Literature
EMCDDA, Lisbon, May 2018
Series type: EMCDDA Papers
Summary
Homicide is a violent act that generates high social costs. In particular, drug-related homicide (DRH) has the potential to act as an indicator of wider drug-related crime...
Aplikace m-Health pro reakci na užívání drog a související škody
Digitální zdravotní péče, známá také jako elektronické zdravotnictví, označuje nástroje a služby, které využívají informační a komunikační technologie ke zlepšení prevence, diagnostiky, léčby, monitorování a řízení zdraví.
Mobilní...
Medical Use of Cannabis and Cannabinoids
The European Monitoring Centre for Drugs and Drug Addiction have released their first report on the medical use of cannabis.
The report is part of a new series called Cannabis, Controversies and Challenges, and is designed to explore the...
Models of Addiction
The science of addiction is complicated, and it continues to be a field where the debate over definitions, models, theories, and the most appropriate ways to respond continues.
EMCDDA's Insight Review provides a critical analysis of the...
Monitoring Drug Use in Recreational Settings across Europe
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) have released their latest technical report “Monitoring Drug Use in Recreational Settings across Europe: Conceptual Challenges and Methodological Innovations”.
The report...
Preventing Overdose Deaths in Europe
There were over 9000 fatal overdoses in Europe in 2016. Tackling this concerning issues remains a key priority for public health policy.
The European Monitoring Centre for Drugs and Drugs Addiction has published their latest perspective...
